Literature DB >> 16785261

A relative reduction in mid-follicular LH concentrations during GnRH agonist IVF/ICSI cycles leads to lower live birth rates.

R Lahoud1, M Al-Jefout, J Tyler, J Ryan, G Driscoll.   

Abstract

BACKGROUND: The effect of early- and mid-follicular LH concentrations on the ovarian response and pregnancy outcomes was evaluated in women receiving pituitary down-regulation with a GnRH agonist and ovarian stimulation with recombinant FSH (rFSH) during IVF/ICSI treatment.
METHODS: Blood samples were collected prospectively from 701 cycles (560 patients) of assisted reproduction and analysed retrospectively. On the basis of LH concentrations on stimulation day 7/8, the patients were divided into two groups: LH<1.2 IU/l (n=179) and LH>or=1.2 IU/l (n=522). Cycle outcomes were also compared on the basis of a ratio of mid- to early-follicular LH concentrations (<or=0.5, n=210; >0.5, n=491).
RESULTS: Patients with low LH concentrations were found to have a significant reduction in the late-follicular estradiol concentrations (P<0.001), the number of oocytes retrieved (P<0.01) and the number of usable embryos (P<0.01), and they required significantly more rFSH (430 IU difference, P<0.01). These differences did not translate into a significant change in live birth rates. Conversely, a ratio of <or=0.5 mid- to early-follicular LH concentrations (a reduction of >or=50%) was associated with a significant reduction in live birth rates per embryo transfer and per cycle started (27.3 versus 19.0%, P<0.05 and 22.2 versus 15.8%, P<0.05, respectively).
CONCLUSIONS: Low mid-follicular levels of LH have a significant impact on ovarian response but not on live birth rates. A fall in LH level of >or=50% from the early- to mid-follicular phase resulted in a lower live birth rate.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16785261     DOI: 10.1093/humrep/del219

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  15 in total

1.  Outcome of in vitro fertilization in patients with proven poor ovarian responsiveness after early vs. mid-follicular LH exposure: a prospective, randomized, controlled study.

Authors:  Alberto Revelli; Alessandra Chiado'; Daniela Guidetti; Francesca Bongioanni; Valentina Rovei; Gianluca Gennarelli
Journal:  J Assist Reprod Genet       Date:  2012-05-29       Impact factor: 3.412

2.  The effect of rLH supplementation to the GnRH-antagonist protocol on endocrine dynamics in the advanced reproductive age.

Authors:  J S Younis; I Izhaki; M Ben-Ami
Journal:  J Endocrinol Invest       Date:  2017-03-13       Impact factor: 4.256

3.  Effects of Low Luteinizing Hormone During Ovarian Stimulation on Endometrial Gene Expression and Function - Transcriptome Analysis During the Implantation Window.

Authors:  Shuo Han; Ming-Hui Liu; Ya-Su Lv; Hai-Ying Ren; Jing Guo; Yuan Li; Shan Liu
Journal:  Reprod Sci       Date:  2022-02-15       Impact factor: 3.060

4.  The ratio of late-follicular to mid-follicular phase LH concentrations efficiently predicts ART outcomes in women undergoing ART treatment with GnRH-agonist long protocol and stimulation with recombinant FSH.

Authors:  Koji Nakagawa; Shirei Ohgi; Akira Nakashima; Takashi Horikawa; Rikikazu Sugiyama; Hidekazu Saito
Journal:  J Assist Reprod Genet       Date:  2008-08-28       Impact factor: 3.412

5.  Reduced FSH and LH action: implications for medically assisted reproduction.

Authors:  E Bosch; C Alviggi; M Lispi; A Conforti; A C Hanyaloglu; D Chuderland; M Simoni; N Raine-Fenning; P Crépieux; S Kol; V Rochira; T D'Hooghe; P Humaidan
Journal:  Hum Reprod       Date:  2021-05-17       Impact factor: 6.918

6.  Live-birth rates after HP-hMG stimulation in the long GnRH agonist protocol: association with mid-follicular hCG and progesterone concentrations, but not with LH concentrations.

Authors:  Joan-Carles Arce; Johan Smitz
Journal:  Gynecol Endocrinol       Date:  2012-07-19       Impact factor: 2.260

Review 7.  Luteinizing hormone and follicle stimulating hormone synergy: A review of role in controlled ovarian hyper-stimulation.

Authors:  Gottumukkala Achyuta Rama Raju; Rahul Chavan; Mamata Deenadayal; Devika Gunasheela; Rohit Gutgutia; Geetha Haripriya; Mirudhubashini Govindarajan; Nayana Hitesh Patel; Ameet Shashikant Patki
Journal:  J Hum Reprod Sci       Date:  2013-10

8.  Combination of recombinant follicle stimulating hormone with human menopausal gonadotrophin or recombinant luteinizing hormone in a long gonadotrophin-releasing hormone agonist protocol: a retrospective study.

Authors:  Gottumukkala Achyuta Rama Raju; S C Teng; Prathigudupu Kavitha; Balabomma Kavitha Lakshmi; Cheemakurthi Ravikrishna
Journal:  Reprod Med Biol       Date:  2012-02-18

9.  Thicker endometrium on hCG trigger day improves the live birth rate of fresh cleavage embryo transfer in GnRH-agonist regimen of normogonadotrophic women.

Authors:  Xi Luo; Yunxiu Li; Haishan Zheng; Lei Ding; Manqin Zhang; Yonggang Li; Ze Wu
Journal:  Ann Transl Med       Date:  2021-05

10.  Low LH Level on the Day of GnRH Agonist Trigger Is Associated With Reduced Ongoing Pregnancy and Live Birth Rates and Increased Early Miscarriage Rates Following IVF/ICSI Treatment and Fresh Embryo Transfer.

Authors:  Abdelhamid Benmachiche; Sebti Benbouhedja; Abdelali Zoghmar; Peter Humaidan
Journal:  Front Endocrinol (Lausanne)       Date:  2019-09-18       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.